Status:
COMPLETED
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Cigarette smoking remains the most common source of preventable morbidity and mortality in the United States, with in excess of $167 billion in economic costs per year. Contingency management (CM), in...
Eligibility Criteria
Inclusion
- regular cigarette smoker
- age ≥ 18
- mailing address \& valid photo I.D.
- want transdermal nicotine
Exclusion
- not English speaking
- in recovery for pathological gambling
- contraindication for transdermal nicotine
- female who is pregnant, nursing a child, or not using effective contraception
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01484717
Start Date
January 1 2012
End Date
December 1 2014
Last Update
February 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030